Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $325.60, but opened at $341.00. Bio-Rad Laboratories shares last traded at $341.00, with a volume of 309 shares traded.
Bio-Rad Laboratories Stock Performance
The firm has a market cap of $9.55 billion, a PE ratio of -12.48 and a beta of 0.72. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14. The firm’s 50 day moving average price is $334.19 and its two-hundred day moving average price is $322.81.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Stories
- Five stocks we like better than Bio-Rad Laboratories
- What is Short Interest? How to Use It
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- P/E Ratio Calculation: How to Assess Stocks
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
